Literature DB >> 12511174

Regional specificity in the neuropathologic substrates of schizophrenia: a morphometric analysis of Broca's area 44 and area 9.

Lynn D Selemon1, Jasna Mrzljak, Joel E Kleinman, Mary M Herman, Patricia S Goldman-Rakic.   

Abstract

BACKGROUND: Numerous recent studies of postmortem schizophrenic brains have reported the presence of structural abnormalities in the dorsolateral prefrontal cortex (dlPFC) that are consistent with a reduction of neuropil. Ventrolateral prefrontal areas have been studied less extensively, and therefore it is not clear whether these cortices exhibit pathologic abnormalities of the same type and magnitude. Because thought disturbances in schizophrenic patients involve language processing, we have performed a morphometric analysis of Broca's area in the ventral frontal lobe.
METHODS: Neuronal and glial density and somal size were assessed via stereologic cell counting in postmortem samples of Broca's area 44 in 9 schizophrenic patients and 14 normal controls. Cell density was reexamined in dorsolateral prefrontal area 9 as an internal control.
RESULTS: We did not detect abnormalities in overall or laminar neuronal density, glial density, cortical thickness, or somal size in area 44 of schizophrenic patients. In contrast, neuronal density in area 9 exhibited a 12% increase in the schizophrenic cohort, replicating previous findings. In addition, there was a significant effect of disease on laminar neuronal density in area 9, with neuronal density tending to be higher (7%-29%) in all layers.
CONCLUSIONS: The absence of significant cytoarchitectonic abnormalities in Broca's area in the same brains in which the dlPFC exhibited an increase in neuronal density suggests that the neuropil deficit is a regionally specific pathologic finding in schizophrenia and indicates that the dlPFC is a particularly vulnerable target of the disease process.

Entities:  

Mesh:

Year:  2003        PMID: 12511174     DOI: 10.1001/archpsyc.60.1.69

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  45 in total

Review 1.  Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand?

Authors:  Nenad Vasic; Bernhard J Connemann; Robert C Wolf; Hayrettin Tumani; Johannes Brettschneider
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-12-16       Impact factor: 5.270

Review 2.  Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions.

Authors:  Deanna M Barch; Erin C Dowd
Journal:  Schizophr Bull       Date:  2010-06-21       Impact factor: 9.306

Review 3.  Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia.

Authors:  Jiri Horacek; Vera Bubenikova-Valesova; Milan Kopecek; Tomas Palenicek; Colleen Dockery; Pavel Mohr; Cyril Höschl
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  Antibodies directed to Neisseria gonorrhoeae impair nerve growth factor-dependent neurite outgrowth in Rat PC12 cells.

Authors:  B Reuss
Journal:  J Mol Neurosci       Date:  2013-11-08       Impact factor: 3.444

5.  Frontal-striatal-thalamic mediodorsal nucleus dysfunction in schizophrenia-spectrum patients during sensorimotor gating.

Authors:  Erin A Hazlett; Monte S Buchsbaum; Jing Zhang; Randall E Newmark; Cathryn F Glanton; Yuliya Zelmanova; M Mehmet Haznedar; King-Wai Chu; Igor Nenadic; Eileen M Kemether; Cheuk Y Tang; Antonia S New; Larry J Siever
Journal:  Neuroimage       Date:  2008-07-11       Impact factor: 6.556

6.  Hemispheric comparisons of neuron density in the planum temporale of schizophrenia and nonpsychiatric brains.

Authors:  John F Smiley; Gorazd Rosoklija; Branislav Mancevski; Denise Pergolizzi; Khadija Figarsky; Cynthia Bleiwas; Aleksej Duma; J John Mann; Daniel C Javitt; Andrew J Dwork
Journal:  Psychiatry Res       Date:  2011-03-05       Impact factor: 3.222

7.  NMDA receptor and schizophrenia: a brief history.

Authors:  Joseph T Coyle
Journal:  Schizophr Bull       Date:  2012-09       Impact factor: 9.306

8.  A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia.

Authors:  Holly Moore; J David Jentsch; Mehdi Ghajarnia; Mark A Geyer; Anthony A Grace
Journal:  Biol Psychiatry       Date:  2006-04-11       Impact factor: 13.382

9.  Reduced neuronal co-localisation of nardilysin and the putative alpha-secretases ADAM10 and ADAM17 in Alzheimer's disease and Down syndrome brains.

Authors:  Hans-Gert Bernstein; Rolf Stricker; Uwe Lendeckel; Iris Bertram; Henrik Dobrowolny; Johann Steiner; Bernhard Bogerts; Georg Reiser
Journal:  Age (Dordr)       Date:  2008-08-30

10.  DTNBP1 is associated with imaging phenotypes in schizophrenia.

Authors:  Katherine L Narr; Philip R Szeszko; Todd Lencz; Roger P Woods; Liberty S Hamilton; Owen Phillips; Delbert Robinson; Katherine E Burdick; Pamela DeRosse; Raju Kucherlapati; Paul M Thompson; Arthur W Toga; Anil K Malhotra; Robert M Bilder
Journal:  Hum Brain Mapp       Date:  2009-11       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.